ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05217	Basal cell carcinoma	8/64	68/7206	1.20068014003e-07
ko03008	Ribosome biogenesis in eukaryotes	8/64	79/7206	3.92549060923e-07
ko04310	Wnt signaling pathway	11/64	181/7206	4.32869727315e-07
ko05200	Pathways in cancer	17/64	492/7206	7.88709578256e-07
ko04550	Signaling pathways regulating pluripotency of stem cells	9/64	165/7206	1.30129021112e-05
ko05206	MicroRNAs in cancer	9/64	177/7206	2.28651545517e-05
ko04390	Hippo signaling pathway	9/64	188/7206	3.68915468188e-05
ko05224	Breast cancer	8/64	174/7206	0.000137433005302
ko05130	Pathogenic Escherichia coli infection	4/64	77/7206	0.00471589587448
ko04150	mTOR signaling pathway	6/64	184/7206	0.00561117951615
ko05202	Transcriptional misregulation in cancer	6/64	188/7206	0.00622202484357
ko04916	Melanogenesis	5/64	142/7206	0.00831534688945
ko05205	Proteoglycans in cancer	7/64	271/7206	0.00979353692224
ko04350	TGF-beta signaling pathway	4/64	103/7206	0.012984791449
ko05166	HTLV-I infection	7/64	292/7206	0.0143606289279
ko05220	Chronic myeloid leukemia	3/64	85/7206	0.0394305488241
ko04110	Cell cycle	4/64	145/7206	0.0394417392403
ko04111	Cell cycle - yeast	3/64	90/7206	0.0454719337469